Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ibiglustat (L-Malic acid) (Ibiglustat L-Malic acid) is a selective, brain-penetrant, and allosteric inhibitor of glucosylceramide synthase. Ibiglustat (L-Malic acid) can be used in studies about PD Parkinson’s disease, SRT in Fabry’s and Gaucher’s.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 55.00 | |
2 mg | In stock | $ 80.00 | |
5 mg | In stock | $ 155.00 | |
10 mg | In stock | $ 229.00 | |
25 mg | In stock | $ 387.00 | |
50 mg | In stock | $ 575.00 | |
100 mg | In stock | $ 823.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 179.00 |
Description | Ibiglustat (L-Malic acid) (Ibiglustat L-Malic acid) is a selective, brain-penetrant, and allosteric inhibitor of glucosylceramide synthase. Ibiglustat (L-Malic acid) can be used in studies about PD Parkinson’s disease, SRT in Fabry’s and Gaucher’s. |
In vitro | Ibiglustat (L-Malic acid) (1 μM) treated Fabry disease cells are close to the physiological level in untreated WT cells in GL-3 levels. Ibiglustat (L-Malic acid) prevents additional GL-3 accumulation and ameliorates the abundant GL-3 levels in FD cardiomyocytes[4]. |
Synonyms | Ibiglustat L-Malic acid, GZ402671 (L-Malic acid), Venglustat (L-Malic acid), SAR402671 (L-Malic acid) |
Molecular Weight | 523.57 |
Formula | C24H30FN3O7S |
CAS No. | 1629063-78-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 90 mg/mL (171.9 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ibiglustat (L-Malic acid) 1629063-78-0 Metabolism Transferase SAR402671 SAR-402671 GZ 402671 Ibiglustat Ibiglustat L-Malic acid GZ402671 (L-Malic acid) SAR 402671 Venglustat Venglustat (L-Malic acid) SAR402671 (L-Malic acid) GZ-402671 L-Malic acid GZ402671 inhibitor inhibit